Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Gynecologic 1Genitourinary 1Gastrointestinal 1CNS 1Breast 1

Conditions

Uterine Neoplasms 1Urinary Bladder Neoplasms 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Pain 1Otorhinolaryngologic Neoplasms 1Head and Neck Neoplasms 1Eye Neoplasms 1Esophageal Neoplasms 1Colonic Neoplasms 1Central Nervous System Neoplasms 1Breast Neoplasms 1

Interventions

pembrolizumab 21Nivolumab 7Docetaxel 7Paclitaxel 5Magnetic Resonance Spectroscopy 5Carboplatin 5Trastuzumab 4Specimen Handling 4Psychiatric Rehabilitation 4Cyclophosphamide 4tisotumab vedotin 3fludarabine 3atezolizumab 3Taxes 3Polymerase Chain Reaction 3Gene Expression Profiling 3Gemcitabine 3Fluorouracil 3Counseling 3Cisplatin 3Albumin-Bound Paclitaxel 3ulixertinib 2poly ICLC 2durvalumab 2belinostat 2X-Rays 2Standard of Care 2Radiotherapy 2Radiation 2Oxaliplatin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Esophageal Neoplasms × D-methadone × Genitourinary × Clear all
NCT00588640 2016-08-10

Study of D-Methadone in Patients With Chronic Pain

Memorial Sloan Kettering Cancer Center

Phase 1/2 Completed
10 enrolled 6 charts
BreastCNSGastrointestinalGenitourinaryGynecologicHead & Neck

Urinary Bladder Neoplasms, Breast Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Eye Neoplasms, Head and Neck Neoplasms, Otorhinolaryngologic Neoplasms, Pain, Pancreatic Neoplasms, Prostatic Neoplasms, Uterine Neoplasms, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡